Coeptis Therapeutics Holdings (COEP) Stock Statistics & Valuation Metrics

Coeptis Therapeutics Holdings has a market cap or net worth of $34.58M. The enterprise value is $32.15M.

Coeptis Therapeutics Holdings has 3,513,838 shares outstanding. The number of shares has decreased by -2.65% in one year.

Coeptis Therapeutics Holdings’s return on equity (ROE) is -3.08 and return on invested capital (ROIC) is -161.25%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Coeptis Therapeutics Holdings had revenue of 0.00 and earned -9.81M in profits. Earnings per share was -5.10.

In the last 12 months, operating cash flow was -7.11M and capital expenditures 0.00, giving a free cash flow of -7.11M billion.

Coeptis Therapeutics Holdings pays an annual dividend of ―, resulting in a dividend yield of ―

Coeptis Therapeutics Holdings upcoming earnings date is ―, ―.

Coeptis Therapeutics Holdings as a current ratio of 0.23, with Debt / Equity ratio of 28.39%

In the past 12 months, Coeptis Therapeutics Holdings has paid -1.06M in taxes.

Coeptis Therapeutics Holdings EV to EBITDA ratio is -1.14, with an EV/FCF ratio of -1.72.

Coeptis Therapeutics Holdings has $4.27M in cash and marketable securities with $1.84M in debt, giving a net cash position of -$2.43M billion.

Gross margin is 13.91%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Coeptis Therapeutics Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―